dermal microvascular endothelial cells hdmec (PromoCell)
PromoCell is a verified supplier 
PromoCell manufactures this product 
94
Structured Review
PromoCell
dermal microvascular endothelial cells hdmec
Dermal Microvascular Endothelial Cells Hdmec, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 146 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hdmec/Human+Dermal+Microvascular+Endothelial+Cells+(HDMEC)+adult+donor/pm42237191-32-14-33
Average 94 stars, based on 146 article reviews
Dermal Microvascular Endothelial Cells Hdmec, supplied by PromoCell, used in various techniques. Bioz Stars score: 94/100, based on 146 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+dermal+microvascular+endothelial+cells+hdmec/Human+Dermal+Microvascular+Endothelial+Cells+(HDMEC)+adult+donor/pm42237191-32-14-33
Average 94 stars, based on 146 article reviews
dermal microvascular endothelial cells hdmec - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
Cell Culture:Article Title: Skin Cell and Tissue Responses to Cross-Linked Hyaluronic Acid in Low-Grade Inflammatory Conditions Article Snippet: As previously stated [ ], human dermal fibroblasts were cultured in a medium consisted in a ratio 1 : 1 of Dulbecco's modified Eagle's medium with Glutamax and F-12 medium (Invitrogen, Cergy Pontoise, France) supplemented with 10% FBS (Sigma-Aldrich, Saint-Quentin-Fallavier, France) and 1% penicillin/streptomycin (Gibco Life Technologies). .. Article Title: Standalone single- and bi-layered human skin 3D models supported by recombinant silk feature native spatial organization. Article Snippet: Accepted Manuscript is “the version of the article accepted for publication including all changes made as a result of the peer review process, and which may also include the addition to the article by IOP Publishing of a header, an article ID, a cover sheet and/or an ‘Accepted Manuscript’ watermark, but excluding any other editing, typesetting or other changes made by IOP Publishing and/or its licensors” This Accepted Manuscript is © 2024 The Author(s).. Published by IOP Publishing Ltd. Modification:Article Title: Skin Cell and Tissue Responses to Cross-Linked Hyaluronic Acid in Low-Grade Inflammatory Conditions Article Snippet: As previously stated [ ], human dermal fibroblasts were cultured in a medium consisted in a ratio 1 : 1 of Dulbecco's modified Eagle's medium with Glutamax and F-12 medium (Invitrogen, Cergy Pontoise, France) supplemented with 10% FBS (Sigma-Aldrich, Saint-Quentin-Fallavier, France) and 1% penicillin/streptomycin (Gibco Life Technologies). .. Recombinant:Article Title: Skin Cell and Tissue Responses to Cross-Linked Hyaluronic Acid in Low-Grade Inflammatory Conditions Article Snippet: As previously stated [ ], human dermal fibroblasts were cultured in a medium consisted in a ratio 1 : 1 of Dulbecco's modified Eagle's medium with Glutamax and F-12 medium (Invitrogen, Cergy Pontoise, France) supplemented with 10% FBS (Sigma-Aldrich, Saint-Quentin-Fallavier, France) and 1% penicillin/streptomycin (Gibco Life Technologies). .. In Vitro:Article Title: Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting Article Snippet: .. For in vitro assays, we used commercially available primary cultures of three cell lines: human umbilical vein endothelial cells (HUVEC) from pooled donors (cat # C-12203, Promocell), Article Title: Pharmacological activation of p53 induces dose-dependent changes in endothelial cell fate during angiogenic sprouting. Article Snippet: .. For in vitro assays, we used commercially available primary cultures of three cell lines: human umbilical vein endothelial cells (HUVEC) from pooled donors (cat # C-12203, Promocell), Article Title: Tubulovascular protection from protease-activated receptor-1 depletion during AKI-to-CKD transition. Article Snippet: Background.. Thromboembolic events are prevalent in chronic kidney disease (CKD) patients due to increased thrombin generation leading to a hypercoagulable state.. We previously demonstrated that inhibition of protease-activated receptor-1 (PAR-1) by vorapaxar reduces kidney fibrosis. |